CYP24A1 and neoplasm: In a study of prostate cancer, changes in the epigenetic patterns of endothelial cells in the tumor microenvironment showed that methylation of the promoter of the gene CYP24A1 plays a role in determining the phenotype of the tumor-associated vasculature [84].